https://www.selleckchem.com/pr....oducts/favipiravir-t
In patients with atrial fibrillation, incomplete adherence to anticoagulants increases risk of stroke. Non-warfarin oral anticoagulants (NOACs) are expensive; we evaluated whether higher copayments are associated with lower NOAC adherence. Using a national claims database of commercially-insured patients, we performed a cohort study of patients with atrial fibrillation who newly initiated a NOAC from 2012 to 2018. Patients were stratified into low ($35), medium ($35-$59), or high (≥$6 copayments and propensity-score weig
Like
Comment
Share
